Drug General Information (ID: DDI02Y3TOK)
  Drug Name Warfarin Drug Info Gemfibrozil Drug Info
  Drug Type Small molecule Small molecule
  Therapeutic Class Anticoagulants Antihyperammonia Agents
  Structure

 Mechanism of Warfarin-Gemfibrozil Interaction (Severity Level: Major)
     Competitive binding of plasma proteins Click to Show/Hide Mechanism Graph
Could Not Find 2D Structure
      Drug Name Warfarin Gemfibrozil
      Mechanism Competition for plasma protein binding sites Competition for plasma protein binding sites
      Key Mechanism Factor 1
Factor Name Plasma protein binding
Factor Description Plasma protein binding refers to the degree of binding of a drug to proteins in the blood, and the lower the degree of binding, the more efficiently the drug can cross cell membranes or diffuse. Plasma protein binding alters the distribution and therapeutic characteristics of the drugs.
      Mechanism Description
  • Increased plasma concentration of Gemfibrozil and Warfarin due to competitive binding of plasma proteins

Recommended Action
      Management Caution should be exercised when fibrates are prescribed to patients receiving oral anticoagulant therapy. Frequent prothrombin determinations are advisable until prothrombin level has stabilized. Patients should be advised to notify their physician if they experience potential signs of excessive anticoagulation such as unusual or prolonged bleeding, bruising, vomiting, change in stool or urine color, headache, dizziness, or weakness.

References
1 Adkins JC, Faulds D "Micronised fenofibrate: a review of its pharmacodynamic properties and clinical efficacy in the management of dyslipidaemia." Drugs 54 (1997): 615-33. [PMID: 9339964]
2 Ascah KJ, Rock GA, Wells PS "Interaction between fenofibrate and warfarin." Ann Pharmacother 32 (1998): 765-8. [PMID: 9681093]
3 Canadian Pharmacists Association.
4 Cerner Multum, Inc. "UK Summary of Product Characteristics.".
5 Harvengt C, Heller F, Desager JP "Hypolipidemic and hypouricemic action of fenofibrate in various types of hyperlipoproteinemias." Artery 7 (1980): 73-82. [PMID: 7247733]
6 Pharmaceutical Society of Australia "APPGuide online. Australian prescription products guide online.".
7 Product Information. Lopid (gemfibrozil). Parke-Davis, Morris Plains, NJ.
8 Product Information. Tricor (fenofibrate). Abbott Pharmaceutical, Abbott Park, IL.
9 Product Information. Trilipix (fenofibric acid). Abbott Pharmaceutical, Abbott Park, IL.